Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
about
A review of the health and economic implications of patent protection, with a specific focus on ThailandCytomegalovirus retinitis: the neglected disease of the AIDS pandemicAre drug companies living up to their human rights responsibilities? Moving toward assessmentElimination of mother-to-child transmission of HIV: lessons learned from success in Thailand.Strategies for price reduction of HIV medicines under a monopoly situation in Brazil.Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literatureAntiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011When to start antiretroviral therapy in resource-limited settings: a human rights analysis.Is endemic political corruption hampering provision of ART and PMTCT in developing countries?Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing worldIntervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.Global health and foreign policy.A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countriesMeasuring adherence to antiretroviral therapy in children and adolescents in western Kenya.Driving a decade of change: HIV/AIDS, patents and access to medicines for all.Government use licenses in Thailand: The power of evidence, civil movement and political leadershipThe first decade of antiretroviral therapy in Africa.A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countriesThe global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.Global challenges in the development and delivery of paediatric antiretrovirals.Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?Access to antiretroviral therapy among HIV/AIDS patients in Chiang Mai province, Thailand.Existing capacity to manage pharmaceuticals and related commodities in East Africa: an assessment with specific reference to antiretroviral therapy.Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries.Changing global essential medicines norms to improve access to AIDS treatment: lessons from BrazilPatent life of antiretroviral drugs approved in the US from 1987 to 2007.Basic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.Initiatives to challenge patent barriers and their relationship with the price of medicines procured by the Brazilian Unified National Health System.Evolution of HIV/AIDS response in Brazil: Policy innovations and challenges in the fourth decade of the epidemic.Gender differences in oral manifestations among HIV-infected Brazilian adults.Challenge and co-operation: civil society activism for access to HIV treatment in Thailand.Compulsory licensing of pharmaceuticals reconsidered: Current situation and implications for access to medicines.International experiences of promoting generics use and its implications to China.PCR detection of multiple human herpesvirus DNA in saliva from HIV-infected individuals in Teresina, State of Piauí, Brazil.Access to Medicines in Resource-limited Settings: The End of a Golden Decade?
P2860
Q27015946-442DEFE8-497F-4C90-A444-DD3EEDA6529FQ28259505-2D1D65C0-C2F7-4C94-917E-DD3BA55938ECQ28475634-394215C8-C9C7-47A8-9937-8A2D846772C7Q30236015-63A56FAE-494A-45C5-9C77-9658C0E5BF47Q30386525-1B9F2ECB-3DD0-4D04-9EEE-5A43EA4D7109Q30394748-63DF1BAE-B74C-4B2F-96DD-15EC4CD159FFQ30801599-7380A015-6B8A-4C46-8C73-5244431F769FQ33548096-464D8426-5072-4E54-90A2-E34C777F119FQ33563924-AD1B3D33-9C32-436D-B93C-AAFD2BA58B20Q33687205-152DDF01-A595-4BF2-B916-2B6D75AD46BCQ33907223-9DBFF6F0-7489-4B1F-A2B0-4AD1A6766003Q33969512-940BD777-EFFA-4062-918B-B29D59939C51Q34152158-C431D9FF-1340-4CA6-A158-65840664B07BQ34577449-E0BDBB22-095C-43D9-8684-A169808C9EEEQ34808796-EE22C94C-B47C-4825-A618-6E911C2A5D19Q35233016-7520CF95-4325-4B06-94BA-86E6A1FD8833Q35337985-6411405B-A5E7-41C4-B265-AA1793944806Q35545912-8216EE41-104D-465A-9619-C96EDD49643EQ35809718-179DD055-FE90-4149-9FFD-64AD013B11C5Q36800408-05AC3E14-9EF7-41A0-9470-C9AC688D110EQ37006157-AB2FCE4C-9AF7-478B-959F-128F97A9F6DBQ37124616-53E06FAC-8E56-404F-A247-83C171D939F1Q37143990-8AAC9733-944C-4568-B1BF-417580FB79EAQ37323399-431F837E-6B0D-4405-B096-E5675D6DE79EQ37402125-BAFA03AD-C97A-413D-BAE4-87BC6236B23BQ37508820-4C31E437-6958-4FD1-ABA9-A589E6BBA04EQ37794235-16D68C5C-E232-4391-A3B3-01ECEC72078BQ39124897-8333A0DE-3662-4EFE-904F-5AD61191A946Q42000417-10E60FF0-80AC-41F0-BB86-7497C9A201EBQ43420072-A668FAE4-0295-43C7-A69E-1CE020E6D18DQ45098699-7BF73B55-E3C9-42BD-A191-67443F9CB32BQ46707957-D8D27DA2-9B03-4DE7-81D0-E54E682EB3B6Q51799607-896451DA-8E71-452D-AC7D-B7626036DC90Q54395883-0B75C9A5-2768-4BFD-90A8-E64AECCF2844Q56967553-9872765E-B848-4ACB-B9ED-ACD967734DA2
P2860
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Sustaining access to antiretro ...... sons from Brazil and Thailand.
@en
type
label
Sustaining access to antiretro ...... sons from Brazil and Thailand.
@en
prefLabel
Sustaining access to antiretro ...... sons from Brazil and Thailand.
@en
P2093
P921
P1433
P1476
Sustaining access to antiretro ...... sons from Brazil and Thailand.
@en
P2093
David Wilson
Gabriela Costa Chaves
Kannikar Kijtiwatchakul
Michel Lotrowska
Nathan Ford
P356
10.1097/01.AIDS.0000279703.78685.A6
P407
P478
21 Suppl 4
P577
2007-07-01T00:00:00Z